Pay-it-forward Gonorrhea and Chlamydia Testing Among Men in China
IGHID 12118 - Pay-it-forward Gonorrhea and Chlamydia Testing Among Men in China: The PIONEER Pragmatic Randomized Controlled Trial
2 other identifiers
interventional
1,200
1 country
1
Brief Summary
PIONEER is a three-arm, programmatic cluster randomized controlled trial (RCT) to compare effectiveness of three implementation strategies, followed by a mixed-methods implementation evaluation study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2023
CompletedFirst Posted
Study publicly available on registry
February 10, 2023
CompletedStudy Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedResults Posted
Study results publicly available
May 16, 2025
CompletedDecember 3, 2025
March 1, 2025
1.3 years
January 27, 2023
April 1, 2025
November 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Testing for Gonorrhea and Chlamydia
Defined as the number of eligible participants who accepted and provided laboratory samples for gonorrhea and chlamydia PCR testing out of the total number of eligible participants recruited across the three study arms.
During enrollment visit
Secondary Outcomes (8)
Donation Amount
Baseline
Number of Participants Who Test Positive for Gonorrhea
Within 2 weeks of enrollment
Number of Participants Who Test Positive for Chlamydia
Within 2 weeks of recruitment
Cost Per Test Per Individual
Baseline - During enrollment visit
Mean Self Reported Gratitude Score
During enrollment visit
- +3 more secondary outcomes
Other Outcomes (3)
Gonorrhea and Chlamydia Testing Uptake by Clinic Type
During enrollment visit
Gonorrhea and Chlamydia Testing Uptake by Sexual Orientation
During enrollment visit
Gonorrhea and Chlamydia Testing Uptake by Age Group
During enrollment visit
Study Arms (3)
Standard Pay-it-forward
EXPERIMENTAL* free gonorrhea/chlamydia testing * minimal engagement
Community engaged Pay-it-forward
EXPERIMENTAL* Free gonorrhea/chlamydia testing * Stronger engagement
Control arm
OTHER* Test available for a fee * No engagement
Interventions
400 men who have sex with men (MSM) at 4 clinics will be enrolled. The standard pay-it-forward arm will include free point-of-care gonorrhea testing, as well as a passive community engagement component (such as viewing postcards and materials written by others encouraging gonorrhea/chlamydia testing).
400 MSM at 4 clinics will be enrolled. The community engaged pay-it-forward arm will include free point-of-care gonorrhea testing, as well as an active community engagement component (such as multi-stakeholder co-creation activities to develop essential components of the intervention and implementation strategies; writing postcards; designing fans with stickers; sending out testing promotion messages on social media; and opportunity to donate to support others)
400 MSM at 4 clinics will be enrolled. The control arm will include a fee-based point-of-care gonorrhea testing (approximately 20 U.S. Dollars (USD) per test) and no community engagement component
Eligibility Criteria
You may qualify if:
- at least 18 years old
- have had sex over the past year
- have not been tested for gonorrhea and chlamydia in the past year
- reside in the city in the past three months
- speak Mandarin Chinese or Cantonese
- mentally capable of providing informed consent to test for gonorrhea and chlamydia
- own a mobile phone
You may not qualify if:
- \< 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dermatology Hospital, Institute for Global Health and Sexually Transmitted Diseases, Southern Medical University, China
Guangzhou, Guangdong, 510095, China
Related Publications (2)
Liu Y, Zhou K, Li L, Salma G, Fitzpatrick T, Marley G, Zhu Z, Tang W, Tucker JD. Financing STI testing among men in China: A mixed-methods study of pay-it-forward monetary donations. PLoS One. 2026 Feb 13;21(2):e0342595. doi: 10.1371/journal.pone.0342595. eCollection 2026.
PMID: 41686825DERIVEDMarley G, Tan RKJ, Wu D, Wang T, Sun M, Sheng Q, Holly ME, Hlatshwako TG, Wang C, Tang W, Ramaswamy R, Yang L, Luo D, Sylvia SS, Gray K, Van Duin D, Zheng H, Tucker JD. Pay-it-forward gonorrhea and chlamydia testing among men who have sex with men and male STD patients in China: the PIONEER pragmatic, cluster randomized controlled trial protocol. BMC Public Health. 2023 Jun 20;23(1):1182. doi: 10.1186/s12889-023-16095-8.
PMID: 37337181DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Joseph Tucker, MD, PhD
- Organization
- University of North Carolina at Chapel Hill
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph D Tucker, MD
University of North Carolina
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2023
First Posted
February 10, 2023
Study Start
April 1, 2023
Primary Completion
July 15, 2024
Study Completion
September 30, 2024
Last Updated
December 3, 2025
Results First Posted
May 16, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- 9 to 36 months following publication
- Access Criteria
- Investigator who proposes to use the data has approval from an IRB, IEC, or REB and an executed data use/sharing agreement with UNC.
Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.